Literature DB >> 21799511

Cytogenetic and therapeutic characterization of primary plasma cell leukemia: the IFM experience.

H Avet-Loiseau, M Roussel, L Campion, X Leleu, G Marit, H Jardel, M Dib, O Decaux, T Lamy, M Tiab, P Cony-Makhoul, A Banos, G Lepeu, F Lifermann, M Macro, B Kolb, C Hulin, D Caillot, C Traulle, C Mathiot, B Royer.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21799511     DOI： 10.1038/leu.2011.176

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  13 in total

1.  Lenalidomide and low-dose dexamethasone for newly diagnosed primary plasma cell leukemia.

Authors:  P Musto; V Simeon; M C Martorelli; M T Petrucci; N Cascavilla; F Di Raimondo; T Caravita; F Morabito; M Offidani; A Olivieri; G Benevolo; R Mina; R Guariglia; G D'Arena; G Mansueto; N Filardi; F Nobile; A Levi; A Falcone; M Cavalli; G Pietrantuono; O Villani; S Bringhen; P Omedè; R Lerose; L Agnelli; K Todoerti; A Neri; M Boccadoro; A Palumbo
Journal:  Leukemia       Date:  2013-08-20       Impact factor: 11.528

2.  A rare case of IGH/MYC and IGH/BCL2 double hit primary plasma cell leukemia.

Authors:  Anna Kalff; Tiffany Khong; Meaghan Wall; Malgorzata Gorniak; Sridurga Mithraprabhu; Lynda J Campbell; Andrew Spencer
Journal:  Haematologica       Date:  2014-11-07       Impact factor: 9.941

Review 3.  How I treat plasma cell leukemia.

Authors:  Niels W C J van de Donk; Henk M Lokhorst; Kenneth C Anderson; Paul G Richardson
Journal:  Blood       Date:  2012-07-26       Impact factor: 22.113

Review 4.  Primary Plasma Cell Leukemia: Identity Card 2016.

Authors:  Pellegrino Musto; Vittorio Simeon; Katia Todoerti; Antonino Neri
Journal:  Curr Treat Options Oncol       Date:  2016-04

Review 5.  Risk Stratification in Multiple Myeloma.

Authors:  Melissa Gaik-Ming Ooi; Sanjay de Mel; Wee Joo Chng
Journal:  Curr Hematol Malig Rep       Date:  2016-04       Impact factor: 3.952

6.  Whole-exome sequencing of primary plasma cell leukemia discloses heterogeneous mutational patterns.

Authors:  Ingrid Cifola; Marta Lionetti; Eva Pinatel; Katia Todoerti; Eleonora Mangano; Alessandro Pietrelli; Sonia Fabris; Laura Mosca; Vittorio Simeon; Maria Teresa Petrucci; Fortunato Morabito; Massimo Offidani; Francesco Di Raimondo; Antonietta Falcone; Tommaso Caravita; Cristina Battaglia; Gianluca De Bellis; Antonio Palumbo; Pellegrino Musto; Antonino Neri
Journal:  Oncotarget       Date:  2015-07-10

7.  Real-world data on prognosis and outcome of primary plasma cell leukemia in the era of novel agents: a multicenter national study by the Greek Myeloma Study Group.

Authors:  Eirini Katodritou; Evangelos Terpos; Sossana Delimpasi; Maria Kotsopoulou; Eurydiki Michalis; Chrysanthi Vadikolia; Marie-Christine Kyrtsonis; Argiris Symeonidis; Nikolaos Giannakoulas; Chrissa Vadikolia; Michalis Michael; Christina Kalpadakis; Theodora Gougopoulou; Chrystalla Prokopiou; Georgia Kaiafa; Dimitrios Christoulas; Maria Gavriatopoulou; Evlampia Giannopoulou; Vasiliki Labropoulou; Evgenia Verrou; Efstathios Kastritis; Pavlina Konstantinidou; Achilles Anagnostopoulos; Meletios A Dimopoulos
Journal:  Blood Cancer J       Date:  2018-03-09       Impact factor: 11.037

Review 8.  Practical management and assessment of primary plasma cell leukemia in the novel agent era.

Authors:  A Visram; A Suska; A Jurczyszyn; W I Gonsalves
Journal:  Cancer Treat Res Commun       Date:  2021-06-08

Review 9.  Molecular Classification and Pharmacogenetics of Primary Plasma Cell Leukemia: An Initial Approach toward Precision Medicine.

Authors:  Vittorio Simeon; Katia Todoerti; Francesco La Rocca; Antonella Caivano; Stefania Trino; Marta Lionetti; Luca Agnelli; Luciana De Luca; Ilaria Laurenzana; Antonino Neri; Pellegrino Musto
Journal:  Int J Mol Sci       Date:  2015-07-30       Impact factor: 5.923

10.  The Bcl-2 specific BH3 mimetic ABT-199: a promising targeted therapy for t(11;14) multiple myeloma.

Authors:  C Touzeau; C Dousset; S Le Gouill; D Sampath; J D Leverson; A J Souers; S Maïga; M C Béné; P Moreau; C Pellat-Deceunynck; M Amiot
Journal:  Leukemia       Date:  2013-07-17       Impact factor: 11.528
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.